Use of GLP-1 agonists for weight loss increases risk of GI AEs

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-023-47379-1
中图分类号
学科分类号
摘要
引用
收藏
页码:12 / 12
相关论文
共 50 条
  • [1] GI Effects of GLP-1 Receptor Agonists
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 191 - 192
  • [2] GLP-1 Agonists for Weight Loss: Pharmacology and Clinical Implications
    Moore, Peyton W.
    Malone, Kevin
    VanValkenburg, Delena
    Rando, Lauren L.
    Williams, Brooke C.
    Matejowsky, Hannah G.
    Ahmadzadeh, Shahab
    Shekoohi, Sahar
    Cornett, Elyse M.
    Kaye, Alan D.
    ADVANCES IN THERAPY, 2023, 40 (03) : 723 - 742
  • [3] GLP-1 Agonists for Weight Loss: Pharmacology and Clinical Implications
    Peyton W. Moore
    Kevin Malone
    Delena VanValkenburg
    Lauren L. Rando
    Brooke C. Williams
    Hannah G. Matejowsky
    Shahab Ahmadzadeh
    Sahar Shekoohi
    Elyse M. Cornett
    Alan D. Kaye
    Advances in Therapy, 2023, 40 : 723 - 742
  • [5] GLP-1 receptor agonists for weight loss- an option in PCOS?
    Boettcher, Bettina
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2023, 21 (01): : 85 - 86
  • [6] Predictors of Pancreatitis on Initiation of GLP-1 Receptor Agonists for Weight Loss
    Postlethwaite, Robert
    Amin, Amin
    Almandoz, Jaime
    Sawas, Tarek
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1035 - S1036
  • [7] GLP-1 receptor agonists in metformin therapy: risk of GI side effects?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 93 - 94
  • [8] Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
    Reiss, Allison B.
    Gulkarov, Shelly
    Lau, Raymond
    Klek, Stanislaw P.
    Srivastava, Ankita
    Renna, Heather A.
    De Leon, Joshua
    BIOMOLECULES, 2025, 15 (03)
  • [9] Risk of thyroid cancer with the use of GLP-1 receptor agonists
    Gouverneur, Amandine
    Penichon, Marine
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 330 - 330
  • [10] Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists
    Vezza, Teresa
    Victor, Victor M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, : 505 - 507